The last thing any company needs especially one that is trying to establish itself in the crowded and growing CGM market is a recall. Unfortunately that’s exactly what happened with Senseonics. Per a story posted on the Mobihealthnews site;
“The FDA has issued a class two device recall for Senseonics’ Eversense continuous glucose monitoring system. This posting follows a September notice from the company that alerted providers and distributors in the US that the sensors of certain devices may stop working prematurely.”
This from the company’s web site:
“Senseonics identified a small number of Eversense Sensors that have . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.